📊 NUS Key Takeaways
Is Nu Skin Enterprises, Inc.. (NUS) a Good Investment?
Nu Skin faces critical operational deterioration with revenue declining 14.3% YoY and deeply negative operating (-$3.9M) and free cash flows (-$17.6M), indicating unsustainable cash burn. Most alarmingly, interest coverage of 0.2x reveals the company cannot service its debt burden from operations, creating material solvency risk despite an adequate near-term cash position of $198.7M.
Revenue is contracting double digits and operating profitability is thin, while the sharp jump in net income appears driven by non-operating items and is not supported by cash flow. The balance sheet is solid with low leverage and good liquidity, but weak cash conversion and declining sales undermine earnings quality and durability.
Why Buy Nu Skin Enterprises, Inc.. Stock? NUS Key Strengths
- Strong gross margin of 66.9% indicates viable product economics and pricing power if operations can be right-sized
- Conservative balance sheet with low leverage (Debt/Equity 0.26x) and sufficient liquidity (Current Ratio 2.03x, Cash $198.7M) providing near-term runway
- Net income up 209.3% YoY demonstrates operational improvements underway, though from a low base of $1.8M
- Strong liquidity (2.08x current, 1.40x quick) with cash exceeding long-term debt
- Low leverage (0.25x D/E) and adequate interest coverage (3.2x)
- High gross margin (69.4%) providing cost headroom
NUS Stock Risks: Nu Skin Enterprises, Inc.. Investment Risks
- Revenue declining 14.3% YoY with operating margin collapsed to 1.3% and net margin near-zero at 0.6%, indicating severe competitive or demand challenges
- Negative operating cash flow (-$3.9M) and free cash flow (-$17.6M) demonstrate company is burning cash operationally and unsustainable at current trajectory
- Interest coverage ratio of 0.2x is critically inadequate; operating income of $4.0M cannot cover interest expense, forcing reliance on asset depletion or refinancing
- ROE of 0.2% and ROA of 0.1% indicate company destroying shareholder value with minimal returns on capital employed
- High insider form 4 activity (21 filings in 90 days) suggests potential management concern about near-term prospects
- Sustained top-line decline (-14.3% YoY) indicates demand pressure
- Thin operating margin (4.4%) and modest coverage heighten downside risk
- Earnings quality concerns: net margin far above operating margin and OCF well below NI, resulting in low FCF margin (3.1%)
Key Metrics to Watch
- Operating Cash Flow trend - must turn positive within 2-3 quarters to validate sustainability
- Revenue stabilization - current -14.3% decline is unsustainable; growth return critical for credibility
- Interest Coverage Ratio - must improve above 1.2x minimum to mitigate solvency risk and refinancing concerns
- Cash burn rate relative to reserves - at current -$17.6M FCF rate, $198.7M cash depletes in ~11 years, but operational improvement is urgent
- Gross margin maintenance - if margins compress further below 66.9%, indicates loss of competitive positioning beyond operational inefficiency
- YoY revenue growth and operating margin
- Operating cash flow to net income (cash conversion)
Nu Skin Enterprises, Inc.. (NUS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.03x current ratio provides a solid financial cushion.
NUS Profit Margin, ROE & Profitability Analysis
NUS vs Market Sector: How Nu Skin Enterprises, Inc.. Compares
How Nu Skin Enterprises, Inc.. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Nu Skin Enterprises, Inc.. Stock Overvalued? NUS Valuation Analysis 2026
Based on fundamental analysis, Nu Skin Enterprises, Inc.. has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Nu Skin Enterprises, Inc.. Balance Sheet: NUS Debt, Cash & Liquidity
NUS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Nu Skin Enterprises, Inc..'s revenue has declined by 27% over the 5-year period, indicating business contraction. The most recent EPS of $0.17 reflects profitable operations.
NUS Revenue Growth, EPS Growth & YoY Performance
NUS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $320.6M | $1.8M | $0.04 |
| Q3 2025 | $364.2M | $8.3M | $0.17 |
| Q2 2025 | $386.1M | $21.1M | $0.43 |
| Q1 2025 | $364.5M | -$533.0K | $-0.01 |
| Q3 2024 | $430.1M | $1.3M | $0.03 |
| Q2 2024 | $439.1M | $26.9M | $0.54 |
| Q1 2024 | $417.3M | -$533.0K | $-0.01 |
| Q3 2023 | $498.8M | $1.3M | $0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Nu Skin Enterprises, Inc.. Dividends, Buybacks & Capital Allocation
NUS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Nu Skin Enterprises, Inc.. (CIK: 0001021561)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NUS
What is the AI rating for NUS?
Nu Skin Enterprises, Inc.. (NUS) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (SELL) with 75% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are NUS's key strengths?
Claude: Strong gross margin of 66.9% indicates viable product economics and pricing power if operations can be right-sized. Conservative balance sheet with low leverage (Debt/Equity 0.26x) and sufficient liquidity (Current Ratio 2.03x, Cash $198.7M) providing near-term runway. ChatGPT: Strong liquidity (2.08x current, 1.40x quick) with cash exceeding long-term debt. Low leverage (0.25x D/E) and adequate interest coverage (3.2x).
What are the risks of investing in NUS?
Claude: Revenue declining 14.3% YoY with operating margin collapsed to 1.3% and net margin near-zero at 0.6%, indicating severe competitive or demand challenges. Negative operating cash flow (-$3.9M) and free cash flow (-$17.6M) demonstrate company is burning cash operationally and unsustainable at current trajectory. ChatGPT: Sustained top-line decline (-14.3% YoY) indicates demand pressure. Thin operating margin (4.4%) and modest coverage heighten downside risk.
What is NUS's revenue and growth?
Nu Skin Enterprises, Inc.. reported revenue of $320.6M.
Does NUS pay dividends?
Nu Skin Enterprises, Inc.. pays dividends, with $2.9M distributed to shareholders in the trailing twelve months.
Where can I find NUS SEC filings?
Official SEC filings for Nu Skin Enterprises, Inc.. (CIK: 0001021561) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NUS's EPS?
Nu Skin Enterprises, Inc.. has a diluted EPS of $0.04.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NUS a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Nu Skin Enterprises, Inc.. has a SELL rating with 75% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is NUS stock overvalued or undervalued?
Valuation metrics for NUS: ROE of 0.2% (sector avg: 15%), net margin of 0.6% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NUS stock in 2026?
Our dual AI analysis gives Nu Skin Enterprises, Inc.. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NUS's free cash flow?
Nu Skin Enterprises, Inc..'s operating cash flow is $-3.9M, with capital expenditures of $13.7M. FCF margin is -5.5%.
How does NUS compare to other Market stocks?
Vs Default sector averages: Net margin 0.6% (avg: 12%), ROE 0.2% (avg: 15%), current ratio 2.03 (avg: 1.8).